[1] |
Jashnani KD, Rupani AB, Wani RJ. Maternal mortality:an autopsy audit. J Postgrad Med, 2009,55(1):12-16.
|
[2] |
Merle P, Trépo C, Zoulim F. Current management strategies for hepatitia B in the elderly.Drugs Aging, 2001,18(10):725-735.
|
[3] |
LI XM, MA L, YANY YB, et al. Clinical characteristics of fulminant hepatitis in pregnancy. World J Gastroenterol, 2005,11(29):4600-4603.
|
[4] |
Yang Y, Deng L, Li X, et al. Analysis of prognosis-associated factor in fulminant viral hepatitis during pregnancy in China. Int J Gynecol Obstet,2011,114(3):242-245.
|
[5] |
LI XM, MA L, YANG YB,et al. Prognostic factors of fulminant hepatitis in pregnancy. Chin Med J (Engl),2005,118(20):1754-1757.
|
[6] |
LI XM, DENG LZ, SHEN HM, et al. Liver synthetic function in predicting the prognosis of pregnancy complicating fulminant hepatitis. Chin Med J (Engl),2007,120(24):2311-2313.
|
[7] |
Potthoff A, Rifai K, Wedemeyer H, et al. Successful treatment of fulminant hepatitis B during pregnancy. Z Gastroenterol,2009,47(7):667-670.
|
[8] |
Khan AA, Shaik MV, Parveen N,et al. Human fetal liver derived stem cell transplantation as supportive modality in the management of end stage decompensated liver cirrhosis. Cell Transplant, 2010, 19(4):409-418.
|
[9] |
Chen H, Yuan L, Tan J, et al. Severe liver disease in pregnancy. Int J Gynecol Obstet, 2008,101(3):277-280.
|